From Wikipedia, the free encyclopedia
Fenleuton
Clinical data
Trade namesLofrin
ATC code
  • none
Identifiers
  • 1-{4-[3-(4-Fluorophenoxy)phenyl]-3-butyn-2-yl}-1-hydroxyurea
CAS Number
ChemSpider
UNII
KEGG
CompTox Dashboard ( EPA)
Chemical and physical data
FormulaC17H15FN2O3
Molar mass314.316 g·mol−1
3D model ( JSmol)
  • CC(C#Cc1cccc(c1)Oc2ccc(cc2)F)N(C(=O)N)O
  • InChI=InChI=1S/C17H15FN2O3/c1-12(20(22)17(19)21)5-6-13-3-2-4-16(11-13)23-15-9-7-14(18)8-10-15/h2-4,7-12,22H,1H3,(H2,19,21)
  • Key:MWXPQCKCKPYBDR-UHFFFAOYSA-N [1]

Fenleuton (trade name Lofrin) is a drug that acts as a 5-lipoxygenase inhibitor and inhibits leukotriene ( LTB4, LTC4, LTD4, and LTE4) formation. It has been studied for potential use in veterinary medicine to treat respiratory diseases such as chronic obstructive pulmonary disease (COPD) in horses. [2]

References

  1. ^ "1-{4-[3-(4-Fluorophenoxy)phenyl]-3-butyn-2-yl}-1-hydroxyurea". chemspider.com. Retrieved 24 December 2015.
  2. ^ Marr KA, Lees P, Page CP, Cunningham FM (1998). "Effect of the 5-lipoxygenase inhibitor, fenleuton, on antigen-induced neutrophil accumulation and lung function changes in horses with chronic obstructive pulmonary disease". J Vet Pharmacol Ther. 21 (3): 241–246. doi: 10.1046/j.1365-2885.1998.00127.x. PMID  9673966.